MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0002930
Sparshmart Pharmaceuticals Private Limited
Sparshmart Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹84.34 Lakh
▲ 179% YoY
Net profit · FY 2025
₹3.59 Lakh
Net margin 4.3%
EBITDA · FY 2025
₹37.7 Lakh
EBITDA margin 44.7%
Authorised capital
₹24 Lakh
Registered with MCA
Paid-up capital
₹17.25 Lakh
Issued & subscribed
Open charges
₹5.1 Cr
Satisfied ₹14.48 Cr
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings
About Sparshmart Pharmaceuticals Private Limited
Data last updated:
Sparshmart Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 May 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2007PTC163921. Its GSTIN is 07AALCS0565J1Z2 (Delhi).
The company has an authorised share capital of ₹24 Lakh and a paid-up capital of ₹17.25 Lakh. It was formerly known as Sparsh Career Network Private Limited. It is led by directors Basant Goel and Tripti Goel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B – 25 Second Floor Okhla Industrial Area Phase – II, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹84.34 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.59 Lakh (net margin 4.3%) and EBITDA of ₹37.7 Lakh (EBITDA margin 44.7%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 18% over five years.
As per MCA filings, the company has open charges of ₹5.1 Cr and satisfied charges of ₹14.48 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.
Sparshmart Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0002930). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Sparshmart Pharmaceuticals Private Limited
CIN U51909DL2007PTC163921
Registration Number 163921
Incorporation Date 24 May 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0002930
CIN History
Sparshmart Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U51909DL2007PTC163921, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909DL2007PTC163921 | Current |
| U80904DL2007PTC163921 | Previous |
| U51900DL2007PTC163921 | Previous |
Key People
Basant Goel Director Tripti Goel Director Recognitions & Rankings of Sparshmart Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB – 25 Second Floor Okhla Industrial Area Phase – II, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Sparshmart Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity
The main business activity of Sparshmart Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Sparshmart Pharmaceuticals Private Limited
FY 2024 filings availableSparshmart Pharmaceuticals Private Limited reported revenue of ₹84.34 Lakh (up 179% YoY) for FY 2025.
Revenue · FY 2025
₹84.34 Lakh ▲ 179%
Net profit · FY 2025
₹3.59 Lakh margin 4.3%
EBITDA · FY 2025
₹37.7 Lakh margin 44.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 179%
3 years · compounded
▲ 9%
5 years · compounded
▼ 18%
EBITDA CAGR growth
1 year
▲ 737%
3 years · compounded
▲ 67%
5 years · compounded
▲ 19%
Revenue rose 179% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 18%. EBITDA rose 737% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹37.7 Lakh | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹3.59 Lakh | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 44.7% | |
| Net Profit Margin | 4.3% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sparshmart Pharmaceuticals are in the company report.
: available in the company report
Board of Directors of Sparshmart Pharmaceuticals Private Limited
Sparshmart Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Basant Goel | Director | 06 Nov 2020 | 5 Years 11 Months | Current |
| Tripti Goel | Director | 06 Nov 2020 | 5 Years 11 Months | Current |
Auditor Details
Sparshmart Pharmaceuticals Private Limited is audited by CHINKY AGGARWAL & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| CHINKY AGGARWAL & CO. | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Open charges
₹5.1 Cr
Satisfied charges
₹14.48 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 May 2024 | Axis Bank Limited | ₹5.1 Cr | Open |
| 14 Aug 2020 | Others | ₹1.48 Cr | Satisfied |
| 27 Aug 2014 | Others | ₹10 Cr | Satisfied |
| 05 Jan 2013 | Vijaya Bank | ₹3 Cr | Satisfied |
Total charge records: 4 View all charges
Legal Cases
Sparshmart Pharmaceuticals Private Limited has 2 court cases on record: 1 filed by Sparshmart Pharmaceuticals, 1 filed against it. All cases are disposed.
Total cases
2
Filed by the company
1
Filed against the company
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North East, Delhi | Civil suit | Filed against the company by M/S Chandra Medicos | Disposed |
| District court, North East, Delhi | Court case (C.S. (COMM)) | Filed by the company against an individual | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays
Sparshmart Pharmaceuticals Private Limited has 7 MSME Form 1 returns on record between 2019 and 2022, listing 28 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Harit Saris and Associates | •••• | •••• | •••• |
| Bajaj Formulation | •••• | •••• | •••• |
| Bajaj Neuraceuticals | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
: available in the company report
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Sparshmart Pharmaceuticals.
: available in the company report
Recent Activity
Sparshmart Pharmaceuticals Private Limited has 8 board changes on record since 2010: 2 appointments and 6 cessations. The latest: Basant Goel ceased to be Additional Director on 30 Dec 2020.
Charges
A charge registered on 14 Aug 2020 via Charge ID 100362343 with Others was fully satisfied on 29 Jul 2025.
Charges
A charge registered on 27 Aug 2014 via Charge ID 10517436 with Others was fully satisfied on 29 Jul 2025.
Charges
A charge with Axis Bank Limited of Rs. 510.00 Lakh registered on 11 May 2024 with Charge ID 100968949 was modified on 25 Feb 2025.
AGM
Sparshmart Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Axis Bank Limited amounted to Rs. 510.00 Lakh with Charge ID 100968949 was registered on 11 May 2024.
Filing
Sparshmart Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Basant Goel ceased to be Additional Director.
Ceased
Tripti Goel ceased to be Additional Director.
Ceased
Sucheta Garg ceased to be Director.
Ceased
Babita Garg ceased to be Director.
Appointed
Basant Goel was appointed as Director.
Appointed
Tripti Goel was appointed as Director.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Sparshmart Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCS0565J1Z2 | Delhi | Active | 01 Jul 2017 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Sparshmart Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 May 2007 (19+ years old) and is registered under CIN U51909DL2007PTC163921.
Sparshmart Pharmaceuticals has 2 current directors:
- Basant Goel - Director
- Tripti Goel - Director
The latest financial statements of Sparshmart Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sparshmart Pharmaceuticals is 07AALCS0565J1Z2, registered in Delhi.
The CIN (Corporate Identification Number) of Sparshmart Pharmaceuticals is U51909DL2007PTC163921. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sparshmart Pharmaceuticals has 2 court cases on record: 1 filed by the company and 1 filed against it.
Sparshmart Pharmaceuticals was incorporated on 24 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
Basant Goel ceased to be Additional Director on 30 Dec 2020. Tripti Goel ceased to be Additional Director on 30 Dec 2020. Sucheta Garg ceased to be Director on 17 Nov 2020. Sparshmart Pharmaceuticals has 8 board changes on record in total.
Yes, Sparshmart Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0002930).
Sparshmart Pharmaceuticals has 7 MSME Form 1 returns on record between 2019 and 2022, listing 28 overdue payments to 4 micro and small suppliers. The latest return was filed on 28 Apr 2022.
The registered office of Sparshmart Pharmaceuticals is at B – 25 Second Floor Okhla Industrial Area Phase – II, New Delhi, Delhi, India – 110020.